218610-56-1 Usage
Molecular structure
Consists of a piperidine ring, a benzoic acid group, and an aminoethylamino side chain.
Usage
Commonly used as a precursor in the synthesis of pharmaceutical drugs.
Potential
A potential candidate for the development of novel therapeutic agents.
Medicinal properties
Ability to interact with biological receptors and enzymes, making it a subject of interest for drug discovery and development.
Versatility
Complex structure and functional groups make it a valuable compound in various fields, including medicinal chemistry and biochemical research.
Check Digit Verification of cas no
The CAS Registry Mumber 218610-56-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,8,6,1 and 0 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 218610-56:
(8*2)+(7*1)+(6*8)+(5*6)+(4*1)+(3*0)+(2*5)+(1*6)=121
121 % 10 = 1
So 218610-56-1 is a valid CAS Registry Number.
218610-56-1Relevant academic research and scientific papers
Alpha 1a adrenergic receptor antagonists
-
, (2008/06/13)
This invention relates to certain novel compounds and derivatives thereof, their synthesis, and their use as alpha 1a adrenergic receptor antagonists. One application of these compounds is in the treatment of benign prostatic hyperplasia. These compounds are selective in their ability to relax smooth muscle tissue enriched in the alpha 1a receptor subtype without at the same time inducing hypotension. One such tissue is found surrounding the urethral lining. Therefore, one utility of the instant compounds is to provide acute relief to males suffering from benign prostatic hyperplasia, by permitting less hindered urine flow. Another utility of the instant compounds is provided by combination with a human 5-alpha reductase inhibitory compound, such that both acute and chronic relief from the effects of benign prostatic hyperplasia are achieved.
